INKON Life Technology Co., Ltd. (SHE:300143)

Market Cap	8.52B +13.5%
Revenue (ttm)	1.97B +27.1%
Net Income	64.31M -46.0%
EPS	0.08 -52.8%
Shares Out	744.93M
PE Ratio	135.57
Forward PE	n/a
Dividend	0.03 (0.22%)
Ex-Dividend Date	n/a

Volume	7,352,659
Average Volume	20,679,494
Open	11.44
Previous Close	11.44
Day's Range	11.29 - 11.52
52-Week Range	8.93 - 14.38
Beta	0.68
RSI	41.41
Earnings Date	Mar 28, 2026

About INKON Life Technology

INKON Life Technology Co., Ltd. focuses on building an ecosystem platform for providing medical services for tumors in China and internationally. It provides medical devices solutions for radiotherapy, life support, image enhancement, and chronic disease treatment; and oncology medical services, as well as equipment for cancer prevention, diagnosis, treatment, and rehabilitation. The company was formerly known as Starmap Medicine and Technology Co., Ltd. and changed its name to INKON Life Technology Co., Ltd. in July 2019. INKON Life Technology...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 2,662
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300143

Financial Performance

In 2025, INKON Life Technology's revenue was 1.89 billion, an increase of 20.93% compared to the previous year's 1.56 billion. Earnings were 68.54 million, a decrease of -40.62%.